Company news
Artelo Biosciences, Inc. news in 2021
Artelo Biosciences, Inc.'s news releases, calls and decks from 2021, newest first.
Artelo Biosciences Reports Fiscal 2021 Year-End Financial Results and Provides Business Update
November 28, 2021
Artelo Biosciences Reports Third Quarter Fiscal 2021 Financial Results and Provides Business Update
July 11, 2021
Artelo Biosciences Announces Two Poster Presentations Featured at the 31st Annual ICRS Symposium
June 21, 2021
Artelo Biosciences Reports Second Quarter Fiscal 2021 Financial Results and Provides Business Update
April 12, 2021
Artelo Biosciences Doses First Patient in CAReS Study with ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
April 11, 2021
Artelo Biosciences Appoints Finance and Healthcare Industry Executive Tamara A. Seymour to Board of Directors
March 8, 2021
Artelo Biosciences Announces Positive Pre-Clinical Data Associated with Proprietary CBD Cocrystal
February 16, 2021
Artelo Biosciences Announces Appointment of Andrew Yates, Ph.D. as Senior Vice President and Chief Scientific Officer
February 15, 2021
Artelo Biosciences Receives $3.0 Million in Net Proceeds from Exercise of Warrants
February 7, 2021
Artelo Biosciences Announces Research Collaboration with Trinity College Dublin to Investigate ART27.13 for the Treatment of Cancer Cachexia
February 1, 2021
Artelo Biosciences Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Update
January 13, 2021